Filter
704
Filtered Results: 704
Text search:
Drug
Prevention
and
Information
Programme
of
the
European
Union
Featured
Recommendations
53
New Publications
150
Language
Document type
No document type
419
Studies & Reports
146
Guidelines
65
Manuals
32
Strategic & Response Plan
23
Fact sheets
9
Situation Updates
5
Training Material
4
Resource Platforms
1
Countries / Regions
Western and Central Europe
75
Eastern Europe
29
Global
26
Sierra Leone
18
Myanmar / Burma
16
Ukraine
15
India
12
Zambia
12
Africa
12
Liberia
11
Kenya
11
Uganda
8
Nigeria
7
Bangladesh
7
Malawi
7
Eastern Europe and Central Asia
7
Lesotho
6
Tajikistan
6
Senegal
5
Ethiopia
5
South Africa
5
Latin America and the Carribbean
5
Guinea
4
Ghana
4
Philippines
4
Nepal
4
Tanzania
4
Cambodia
4
Rwanda
4
Namibia
4
Eswatini/ Swaziland
4
Middle East and North Africa
4
Asia
4
Russia
4
Thailand
3
Botswana
3
West and Central Africa
3
Albania
3
Laos
3
Moldova
3
Georgia
3
Burkina Faso
2
Zimbabwe
2
South Sudan
2
Germany
2
North Macedonia
2
East and Southern Africa
2
Vietnam
2
Congo, Democratic Republic of
1
USA
1
Somalia
1
Pakistan
1
Iraq
1
Afghanistan
1
Turkey
1
Syria
1
Indonesia
1
Ireland
1
Sudan
1
Benin
1
Brazil
1
Serbia
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Poland
1
Armenia
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
173
Clinical Guidelines
57
Public Health
46
Pharmacy & Technologies
19
Key Resources
13
Women & Child Health
10
Capacity Building
5
Toolboxes
HIV
117
TB
117
Mental Health
90
AMR
60
COVID-19
26
Pharmacy
23
Rapid Response
19
Refugee
15
Planetary Health
14
NCDs
14
Ebola
13
Global Health Education
10
Disability
9
Conflict
9
Caregiver
7
NTDs
7
Health Financing Toolbox
7
Polio
3
Natural Hazards
2
Cholera
1
Zika
1
Specific Hazards
1
Social Ethics
1
Health Financing
1
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodefic...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health ... HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents. The Global Action Plan has five strategic objectives: 1) prevention and response; 2) monitoring and surveillance; 3) research and innovation; 4) laboratory capacity; and 5) governance and enabling mechanisms.
The Global status report on violence prevention 2014, which reflects data from 133 countries, is the first report ... its kind to assess national efforts to address interpersonal violence, namely child maltreatment, youth violence, intimate partner and sexual violence, and elder abuse. Jointly published by WHO, the United Nations Development Programme, and the United Nations Office on Drugs and Crime, the report reviews the current status of violence prevention efforts in countries, and calls for a scaling up of violence prevention programmes; stronger legislation and enforcement of laws relevant for violence prevention; and enhanced services for victims of violence.
You can download summaries in different languages, single chapters and graphics
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries ... territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth GLASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.
A summary of the national drug situation
A summary of the national drug situation
A summary of the national drug situation
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The... main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical conditions, and socio-demographic factors.
This protocol establishes the principles and definitions of a surveillance system devised by the...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framewo...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant ...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes...
This publication aims to provide examples of better palliative care practices for older people to help those involved in planning and supporting care-oriented services most appropriately <... effectively. Examples have been identifi ed from literature searches and from an international call for examples through various organizations, including the European Association of Palliative Care and the European Union Geriatric Medicine Society. Some examples consider how to improve aspects within the whole health system; specifi c smaller examples consider how to improve palliative care education, support in the community, in hospitals or for specifi c groups of people, such as people in nursing homes and people with dementia and their families. Some examples await rigorous evaluation of effectiveness, and more research is needed in this fi eld, especially the cost–effectiveness and generalizability of these initiatives.
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, lab...
The five hepatitis viruses have different epidemiological profiles, and their impact, duration, and transmission route also vary. ... most common transmission routes contributing to the spread of hepatitis are exposure to infected blood via blood transfusion or unsafe injection practices, consumption of contaminated food and drinking water, and transmission from mother to child during pregnancy and delivery. Also, unsafe injection practices, including the use of unsterile needles and syringes, serve as a major pathway for the spread of hepatitis B and C, and reducing transmission of both diseases requires addressing these practices.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the firs...
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contributio...
One of the most important ways we feel we can help to reduce the burden of cancer in Africa is t...
